This effect seems to be dependent on conversion of estrogen to 16αOHE1 as inhibition of CYP1B1, by 2,3′,4,5′-tetramethoxystilbene, normalized Nrf2 activity in PAH-hPASMCs (Figure 3A). This evidence concerns the gene CYP1B1 and pulmonary arterial hypertension.